Edwards Lifesciences Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Edwards Lifesciences Corporation inventory turnover ratio, the Edwards Lifesciences Corporation's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 1.28 in the second quarter 2026, yet the ratio remained below the average, as EW's market remain challenging.Average inventory processing period, for the Edwards Lifesciences in Jun 30 2026 quarter, has decreased to 285 days, compare to 297 days, in the Mar 31 2026 quarter.

Within Healthcare sector 285 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 826 in the first quarter 2026, to 1760.

EW Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Edwards Lifesciences Corporation Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

EW Inventory Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Inventory Growth	-0.92 %	0.46 %	3.63 %	3.32 %	11.42 %
Y / Y Cost of Sales Growth	14.07 %	20.27 %	85.95 %	31.68 %	20.7 %
Inventory Turnover Ratio (TTM)	1.28	1.23	1.18	1.05	0.98
EW's Total Ranking	# 1760	# 826	# 826	# 1318	# 757
Average inventory processing period	286	296	309	348	372
Seq. Inventory Growth	1.09 %	-0.64 %	-1.29 %	-0.07 %	2.5 %
Seq. Cost of Sales Growth	8.4 %	5.23 %	-0.29 %	0.29 %	14.29 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 131
Healthcare Sector	# 286
Overall Market	# 1760

Inventory Turnover Ratio Statistics
High	Average	Low
2.37	1.64	0.95
(Sep 30 2014)		(Mar 31 2025)

EW Company Profile >> Back to EW Efficiency Comparisons >> Compare EW Inventory Turnover Ratio to its Competitors

Financial Statements
Edwards Lifesciences's Inventories	$ 1,131 Millions	Visit EW's Balance sheet
Edwards Lifesciences's Cost of Revenues TTM	$ 1,443 Millions	Visit EW's Income Statement
What are EW's Sales?		Visit EW's Sales by Segment

Other Inventory Turnover Ratios
Edwards Lifesciences's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
EW's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for EW's Competitors
Inventory Turnover Ratio for EW's Suppliers
Inventory Turnover Ratio for EW's Customers

You may also want to know
EW's Sales Growth Rates	EW's Pe Price to earnings ratio	EW's Receivables Turnover Ratio	EW's Stock Quote
EW's Net Income Growth Rates	EW's Ps Price to Sales ratio	EW's Sales per Employee	EW's Asset Turnover Ratio
EW's Net Margin	EW's Pb Price to Book ratio	EW's Financial Strength Ratios	EW's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Jun 30 2026	Inventories at quarter ending Jun 30 2026
Nexgel Inc	3.49	$ 7.577 Millions	$ 2 Millions
Lifeward ltd	3.47	$ 13.976 Millions	$ 4 Millions
Bellevue Life Sciences Acquisition Corp	3.38	$ 1.215 Millions	$ 0 Millions
10x Genomics Inc	3.29	$ 184.539 Millions	$ 56 Millions
Biofrontera Inc	3.28	$ 6.622 Millions	$ 2 Millions
Maravai Lifesciences Holdings Inc	3.22	$ 135.038 Millions	$ 42 Millions
Agilent Technologies inc	3.20	$ 3,404.000 Millions	$ 1,064 Millions
Mettler toledo International Inc	3.18	$ 1,277.460 Millions	$ 401 Millions
Bionexus Gene Lab Corp	3.15	$ 2.362 Millions	$ 1 Millions
Eton Pharmaceuticals Inc	3.11	$ 44.176 Millions	$ 14 Millions
Mimedx Group Inc	3.07	$ 75.981 Millions	$ 25 Millions
Revvity Inc	2.98	$ 1,136.473 Millions	$ 381 Millions
Amneal Pharmaceuticals Inc	2.98	$ 1,891.689 Millions	$ 635 Millions
Resmed Inc	2.97	$ 2,770.562 Millions	$ 933 Millions
Msa Safety Inc	2.92	$ 1,021.036 Millions	$ 350 Millions
Ligand Pharmaceuticals Incorporated	2.91	$ 32.387 Millions	$ 11 Millions
Logicmark Inc	2.83	$ 3.881 Millions	$ 1 Millions
Merck and Co Inc	2.79	$ 17,996.000 Millions	$ 6,447 Millions
Inspiremd Inc	2.78	$ 8.847 Millions	$ 3 Millions
Ani Pharmaceuticals Inc	2.69	$ 387.398 Millions	$ 144 Millions
International Stem Cell Corporation	2.61	$ 4.285 Millions	$ 2 Millions
Biomerica Inc	2.59	$ 4.091 Millions	$ 2 Millions
Evofem Biosciences Inc	2.58	$ 4.418 Millions	$ 2 Millions
Nephros Inc	2.54	$ 8.991 Millions	$ 4 Millions
Illumina Inc	2.52	$ 1,510.000 Millions	$ 599 Millions
IMPACT BIOMEDICAL INC.	2.46	$ 0.414 Millions	$ 0 Millions
Quidelortho Corp	2.45	$ 1,481.500 Millions	$ 605 Millions
Pro dex Inc	2.43	$ 53.213 Millions	$ 22 Millions
Angiodynamics Inc	2.43	$ 142.834 Millions	$ 59 Millions
Journey Medical Corp	2.42	$ 23.556 Millions	$ 10 Millions

Date modified: 2026-08-30T14:06:18+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.